JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
1.530
+0.010 (0.65%)
May 2, 2025, 11:22 AM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 620.07 million as of May 1, 2025. Its market cap has decreased by -18.26% in one year.
Market Cap
620.07M
Enterprise Value
263.60M
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.53
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 620.07M, a decrease of -92.51%. That is a compound annual growth rate of -43.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2025 | 620.07M | 19.70% |
Dec 31, 2024 | 518.01M | -42.89% |
Dec 29, 2023 | 907.01M | -47.90% |
Dec 30, 2022 | 1.74B | -67.36% |
Dec 31, 2021 | 5.33B | -47.83% |
Dec 31, 2020 | 10.22B | 23.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeiGene | 208.52B |
Hansoh Pharmaceutical Group Company | 140.02B |
JD Health International | 117.67B |
WuXi Biologics | 93.60B |
Innovent Biologics | 88.42B |
Alibaba Health Information Technology | 79.45B |
Akeso | 78.36B |
Sichuan Kelun-Biotech Biopharmaceutical | 75.45B |